Gene · 92
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of Fisetin as a potent and cell-active ACVR2A inhibitor. | Bioorg Med Chem Lett | 2027 | 42801961 | PubTator, text mining | PubMed |
| Activins and BMPs: The yin and yang of diffuse midline gliomas. | Cell Stem Cell | 2026 | 42822433 | PubTator, text mining | PubMed |
| Physiological Aging and Cardiovascular Disease Distinctly Remodel the Human Cardiac Lymphatic Endothelium. | bioRxiv | 2026 | 42818248 | PubTator, text mining | PubMed |
| GDF3 is an endogenous antagonist of the ActE-ALK7/ACVR2 pathway in adipocytes. | bioRxiv | 2026 | 42818110 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identifies Candidate Genomic Features Associated with Response to Platinum-Based Chemotherapy and Ixabepilone-Based Treatment in Ovarian Cancer. | Int J Mol Sci | 2026 | 42737428 | PubTator, text mining | PubMed |
| Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review. | Pulm Circ | 2026 | 42516684 | PubTator, text mining | PubMed |
| Etiology-Driven Mouse Models of Hepatocellular Carcinoma: Paving the Way for Precision Oncology. | J Hepatocell Carcinoma | 2026 | 42438783 | PubTator, text mining | PubMed |
| Myostatin Signaling in Skeletal Muscle: Implications for Athletic Performance. | Compr Physiol | 2026 | 42322019 | PubTator, text mining | PubMed |
| Evaluation of Droplet Digital PCR Assay for the Detection of Microsatellite Instability in Colorectal, Gastric, and Endometrial Cancers. | Diagnostics (Basel) | 2026 | 42196916 | PubTator, text mining | PubMed |
| Molecular landscape and biomarker associations of functional NTRK fusions: a real-world retrospective cohort study across solid tumors. | Transl Cancer Res | 2026 | 41969448 | PubTator, text mining | PubMed |
| Targeting the activin/myostatin - actrii pathway to preserve skeletal muscle mass in obesity: mechanistic insights and therapeutic perspectives. | Rev Endocr Metab Disord | 2026 | 41954678 | PubTator, text mining | PubMed |
| BMPR2 Dosage Gates BMP9/10 Signaling Output in Pulmonary Artery Endothelium. | Cells | 2026 | 41892283 | PubTator, text mining | PubMed |
| Uniform Processing of Diverse Sequencing Data: A Cross-Population Comparison of Colon Cancer Genomic Landscapes from The Cancer Genome Atlas and a Chinese Cohort. | Cancer Epidemiol Biomarkers Prev | 2026 | 41824468 | PubTator, text mining | PubMed |
| Glucagon-like peptide-1 receptor agonists in orthopaedics. | SICOT J | 2026 | 41789832 | PubTator, text mining | PubMed |
| Tailoring low-dose aspirin to prevent preeclampsia: translational and biomarker insights. | Front Med (Lausanne) | 2026 | 41788727 | PubTator, text mining | PubMed |
| Spinal cord injury-induced overflow incontinence reshapes the activin-follistatin-inhibin axis in mouse bladder and kidney. | Front Mol Biosci | 2026 | 41788624 | PubTator, text mining | PubMed |
| Fibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review. | Cancer Genomics Proteomics | 2026 | 41771581 | PubTator, text mining | PubMed |
| Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma. | Int J Mol Sci | 2026 | 41752158 | PubTator, text mining | PubMed |
| Decoding the Endocrine Code of Skeletal Muscle: Myokines, Exerkines, and Inter-Organ Crosstalk in Metabolic Health and Disease. | Cells | 2026 | 41744761 | PubTator, text mining | PubMed |
| Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient. | Cell Oncol (Dordr) | 2026 | 41733805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92/papers